Sub Banner Image

London IPOs Hit 28-Year Low Amid AstraZeneca Exit Concerns

Markets

Pablo Mayo Cerqueiro, Joe Easton, Neil Campling

·

July 2, 2025

·

Bloomberg

London marked the slowest first half-year for IPO volume since 1997, a grim milestone punctuated by a report that AstraZeneca Plc’s chief executive officer wants to move the company’s listing to the US.

More from

Bloomberg

More

Markets

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.